Maverick Capital Ltd. Invests $1.71 Million in The Clorox Company $CLX

Maverick Capital Ltd. acquired a new position in shares of The Clorox Company (NYSE:CLX) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 16,486 shares of the company’s stock, valued at approximately $1,708,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CLX. State Street Corp raised its stake in Clorox by 3.5% during the third quarter. State Street Corp now owns 8,434,277 shares of the company’s stock worth $1,039,946,000 after acquiring an additional 282,794 shares in the last quarter. Invesco Ltd. boosted its stake in shares of Clorox by 22.1% in the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock valued at $492,085,000 after purchasing an additional 884,751 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Clorox by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company’s stock valued at $318,613,000 after purchasing an additional 10,060 shares in the last quarter. Van ECK Associates Corp grew its holdings in shares of Clorox by 15.7% during the 4th quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company’s stock valued at $316,244,000 after purchasing an additional 426,433 shares during the last quarter. Finally, Two Sigma Investments LP grew its holdings in shares of Clorox by 33.8% during the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock valued at $214,564,000 after purchasing an additional 439,797 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Insider Buying and Selling

In related news, Director Pierre R. Breber bought 5,000 shares of the business’s stock in a transaction on Tuesday, May 5th. The shares were purchased at an average cost of $85.82 per share, with a total value of $429,100.00. Following the acquisition, the director owned 18,000 shares of the company’s stock, valued at $1,544,760. This represents a 38.46% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.63% of the company’s stock.

Clorox Price Performance

CLX stock opened at $97.50 on Tuesday. The company has a fifty day moving average price of $95.19 and a 200-day moving average price of $103.83. The company has a market capitalization of $11.79 billion, a P/E ratio of 15.83 and a beta of 0.54. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $130.41. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, topping the consensus estimate of $1.55 by $0.09. The company had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. Clorox’s revenue for the quarter was up .1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, equities analysts expect that The Clorox Company will post 5.52 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on CLX shares. The Goldman Sachs Group reissued a “sell” rating and issued a $83.00 price objective on shares of Clorox in a research note on Friday, May 1st. Morgan Stanley decreased their target price on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research note on Friday, May 1st. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $94.00 price target on shares of Clorox in a report on Wednesday, July 22nd. Royal Bank Of Canada dropped their price target on Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a research note on Thursday, April 9th. Finally, JPMorgan Chase & Co. reduced their price objective on Clorox from $95.00 to $92.00 and set an “underweight” rating on the stock in a research report on Thursday, July 16th. One investment analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Reduce” and an average target price of $102.80.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.